High-intensity cholesterol pills for people with silent calcium
Part of Hormones & metabolism clinical trials.
This trial studies whether high-intensity statin plus ezetimibe can improve heart health in people who do not have symptoms but have calcium buildup in their heart arteries. It may help lower cholesterol and reduce future heart risks for the right participants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40 or older.
- You have no heart symptoms but your heart scan shows coronary calcium (Agatston score 100 or higher).
- Your LDL (“bad cholesterol”) is under 190 mg/dL.
- You have not had stroke (cerebrovascular disease) in the past.
- You do not have known moderate-to-severe reduced blood flow to the heart that would need a procedure (revascularization).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how well a combination cholesterol medication (pitavastatin and ezetimibe) works in people who have high cholesterol and metabolic syndrome (a cluster of health issues including high blood pressure, blood sugar, and cholesterol). You'll be monitored over time to see if the medication helps and is safe for you.
This trial tests if pitavastatin alone or with ezetimibe affects blood sugar differently than atorvastatin in people who have heart or blood vessel disease and metabolic syndrome but do not have diabetes.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
This trial tests whether taking a moderate-strength statin (cholesterol-lowering drug) plus ezetimibe (another cholesterol medicine) together helps protect the heart and kidneys in people who have both chronic kidney disease and established heart disease or stroke history.
This trial compares a combo of statin and ezetimibe without aspirin against statin alone with aspirin in people with high coronary calcium but no blocked arteries. It aims to find which approach is safer and more effective without causing bleeding risk.
This study tests whether combining a low-dose statin with ezetimibe is safe and effective for people who have very early signs of plaque buildup in their arteries but are not yet at high risk. The goal is to see if this combination can prevent heart disease from getting worse.
Hear when a new Coronary Artery Calcification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.